Globeflex Capital’s Zimmer Biomet ZBH Stock Holding History

Globeflex Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,228	Closed	-$648K	–	535
2019 Q1	$648K	Sell	5,228 -1,702	-25%	-$193K	0.14%	252
2018 Q4	$698K	Hold	6,930	–	–	0.17%	215
2018 Q3	$885K	Hold	6,930	–	–	0.17%	211
2018 Q2	$750K	Sell	6,930 -110	-2%	-$12K	0.15%	226
2018 Q1	$745K	Hold	7,040	–	–	0.16%	223
2017 Q4	$825K	Sell	7,040 -583	-8%	-$65.9K	0.23%	169
2017 Q3	$867K	Sell	7,623 -121	-2%	-$14K	0.25%	155
2017 Q2	$965K	Buy	+7,744	New	+$918K	0.24%	168
2015 Q4	–	Sell	-10,306	Closed	-$940K	–	514
2015 Q3	$940K	Buy	+10,306	New	+$1.03M	0.2%	171
2013 Q4	–	Sell	-51,107	Closed	-$4.08M	–	688
2013 Q3	$4.08M	Buy	51,107 +73	+0.1%	+$5.75K	0.52%	81
2013 Q2	$3.71M	Buy	+51,034	New	+$3.82M	0.51%	85

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Globeflex Capital's ZBH Position: Q2 2019 in Review

Globeflex Capital sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 5,228 shares — an estimated $648K sold.

Globeflex Capital first reported a position in ZBH in Q2 2013 and held it in 11 quarters. The position peaked at $4.08M in Q3 2013. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Globeflex Capital reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Globeflex Capital sold 5,228 Zimmer Biomet shares in Q2 2019, an estimated $648K.
Globeflex Capital first reported a position in Zimmer Biomet in Q2 2013 and held it in 11 quarters.
Globeflex Capital's Zimmer Biomet position peaked at $4.08M in Q3 2013.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Globeflex Capital's 13F filing for Q2 2019, filed 12 Aug 2019.